Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Prosecution Criteria For “Responsible” Execs Includes Seriousness, Obviousness Of Violations

Executive Summary

Almost a year after signaling its intent to target more individual executives with misdemeanor prosecutions when their companies have broken the law, FDA has published its criteria for pursuing such cases.
Advertisement

Related Content

Park Doctrine’s Use Should Hinge On Individual’s Knowledge Of Wrongdoing, Prosecutor Says
Park Doctrine Could Be Limited By Upcoming Cases, Attorney Argues
Former KV Pharmaceutical CEO Sentenced To 30 Days In Jail
Presumed Guilty: HHS Exclusion Guidance Shifts Burden Of Proof To Corporate Officers
Off-Label Prosecution May Be Where FDA "Parks" Aggressive Enforcement Tools First
Corporate Responsibility Standards Coming; Don't Be First Case, FDA Warns
Corporate Responsibility Standards Coming; Don't Be First Case, FDA Warns

Topics

Advertisement
UsernamePublicRestriction

Register

PS053091

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel